Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A oligodendroglioma that involves the corpus callosum.
Biomarker and diagnostic research for corpus callosum oligodendroglioma has been reported in the published literature.
No clinical trials have been registered for corpus callosum oligodendroglioma.
7 publications have been identified in PubMed for corpus callosum oligodendroglioma. Research spans Clinical Trial Publication (33%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Sumi T (2026). [PMID: 41813180](https://pubmed.ncbi.nlm.nih.gov/41813180/). *Neurol Med Chir (Tokyo)*. [Diagnostic / Biomarker]
Ge Z (2026). [PMID: 41242200](https://pubmed.ncbi.nlm.nih.gov/41242200/). *Surg Oncol*. [Review / Meta-Analysis]
Duffau H (2025). [PMID: 40644717](https://pubmed.ncbi.nlm.nih.gov/40644717/). *J Neurosurg*. [Clinical Trial Publication]
Shimoda Y (2025). [PMID: 40358745](https://pubmed.ncbi.nlm.nih.gov/40358745/). *Acta Neurochir (Wien)*. [Clinical Trial Publication]
van Veggel L (2025). [PMID: 40138922](https://pubmed.ncbi.nlm.nih.gov/40138922/). *Biomed Pharmacother*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC